Lithium-induced Hyperparathyroidism and Hypercalcemia
- PMID: 31309015
- PMCID: PMC6609280
- DOI: 10.7759/cureus.4590
Lithium-induced Hyperparathyroidism and Hypercalcemia
Abstract
Lithium is one of the mainstays of treatment for bipolar disorder. Chronic lithium therapy can rarely lead to hypercalcemia secondary to lithium-induced hyperparathyroidism. We present a 66-year-old female patient with bipolar disorder on lithium therapy presenting with hypercalcemia. We discussed the pathophysiology and management of hyperparathyroidism and hypercalcemia in patients on chronic lithium therapy.
Keywords: hypercalcemia; hyperparathyroidism; lithium.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

References
-
- Hyperparathyroidism with lithium [Article in French] Brochier T, Adnet-Kessous J, Barillot M, Pascalis JG. https://www.ncbi.nlm.nih.gov/pubmed/8088238. Encephale. 1994;20:339–349. - PubMed
-
- Hypothyroidism and hyperparathyroidism associated with lithium. Garfinkel P, Ezrin C, Stancer H. Lancet. 1973;302:331–332. - PubMed
-
- Lithium-associated hyperparathyroidism: report of four cases and review of the literature. Szalat A, Mazeh H, Freund HR. Eur J Endocrinol. 2009;160:317–323. - PubMed
-
- Clinical manifestations of hypercalcemia. [Apr;2019 ];Shane Shane, Elizabeth Elizabeth. https://www.uptodate.com/contents/clinical-manifestations-of-hypercalcemia Uptodate , 24 Apr. 2019
Publication types
LinkOut - more resources
Full Text Sources